A Study in Adult Subjects With Select Advanced Solid Tumors

Study identifier:D6150C00001

ClinicalTrials.gov identifier:NCT02583165

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase 1 Study of MEDI1873 (GITR Agonist) in Adult Subjects With Select Advanced Solid Tumors

Medical condition

Advanced Solid Tumors

Phase

Phase 1

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

40

Study type

Interventional

Age

18 Years - 130 Years

Date

Study Start Date: 09 Nov 2015
Primary Completion Date: 19 Dec 2018
Study Completion Date: 19 Dec 2018

Study design

Allocation: N/A
Endpoint Classification: Safety/Efficacy
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jun 2020 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria